Bioline Rx reported $20.83M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Arca Biopharma USD 486.72M 17.72M Mar/2026
Bio Path USD -8.49M 482K Mar/2026
Bioline Rx USD 20.83M 2.64M Mar/2026
Capricor Therapeutics USD 278.7M 27.09M Mar/2026